Cohen Veterans Bioscience announced findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder (PTSD) or major depressive disorder (MDD) towards the most effective treatment. We are excited to virtually attend and exhibit at the 2020 CNS Summit, October 29 – November 1, 2020. This annual event convenes innovators across industry, academia, media, non-profit organizations, and others to enable networking, discussion, and collaboration in clinical development.RECENT NEWS
Help us fast-track diagnostics and treatments for Post-Traumatic Stress Disorder (PTSD) & Traumatic Brain Injury (TBI).
We Need Precision Medicine for The Brain
We bring together the brightest minds and deploy the most innovative scientific tools with an emphasis on scale, risk-minimization, efficiency and speed.
Recent Highlights
News
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
Events
Cohen Veterans Bioscience Virtually Attending & Exhibiting at the 2020 CNS Summit
Donate Now
